KR

Kiara Rangwani

Active Director Director DIN 07922591
DIN 07922591 First appointment Sep 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2017
Shareholding value •••• Premium profile

About Kiara Rangwani

Data last updated:

Kiara Rangwani is a Director at Rangwani Pharmaceuticals Private Limited (since 2017). The company operates in Pharma. Rangwani Pharmaceuticals Private Limited reported revenue of ₹2.67 Cr (FY 2024).

DIN 07922591
Primary Designation Director
Industry Pharma
First Appointment 01 Sep 2017
Oldest Company Age 9 yrs
Largest company Rangwani Pharmaceuticals Private Limited · ₹2.67 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Sep 20172017₹2.67 Cr (FY 2024)Active

Board colleagues of Kiara Rangwani

Directorship timeline

Open interactive timeline →
Rangwani Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kiara Rangwani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kiara Rangwani

Kiara Rangwani currently holds 1 directorship: Rangwani Pharmaceuticals Private Limited (Director, since 01 Sep 2017, revenue ₹2.67 Cr (FY 2024)).

Kiara Rangwani was first appointed on 01 Sep 2017 as Director at Rangwani Pharmaceuticals Private Limited.

The current boards of Kiara Rangwani's companies include Anjali Rangwani (Rangwani Pharmaceuticals Private Limited), Deepak Rangwani (Rangwani Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available